The beginning of the year saw a spurt of IPO activity, but it's since cooled off. A declining stock market and pullback from ...

With little risk of inflation spiking higher, the RBA could comfortably move to cut interest rates on Tuesday. But it's ...

Jennifer Schneider is the CEO of UK-based Centauri Therapeutics, which is developing an immunotherapy for infectious disease that can help patients who don’t respond well to traditional ...

Affirm Holdings, Inc. AFRM is expanding its payment solutions with two major partnerships: one with JPMorgan Chase & Co. JPM ...

Following Nvidia's (NVDA) recent announcement at GTC 2025 that it plans to scale artificial intelligence factories with ...

Healthcare Analysts provide expert insights on current and emerging treatments for Systemic Mastocytosis (relevant companies Blueprint ...

WuXi AppTec (Shanghai, China) has sold off two US/UK businesses in February and March, it revealed in its annual results on ...

At the JP Morgan Healthcare Conference in January, pharmaphorum editor-in-chief Jonah Comstock caught up with Bradley Bostic, ...

The CARAai platform supports a wide range of enterprise healthcare and life sciences use cases and solutions. Over the course of 2025, ConcertAI will be launching a series of new AI SaaS solutions ...

At a time when CRISPR companies have struggled, the Feng Zhang spinoff Arbor Biotechnologies gets a cash infusion to head to clinical trials.

At the 2025 JP Morgan Healthcare Conference, the company announced new partnerships with clinical research services company ...

During the week of the 2025 J.P. Morgan Healthcare Conference in San Francisco, life sciences partners Suzanne Filippi and Laurie Burlingame led ...